ISCD Learning
December 2023 - Quality Bone Densitometry: Performance, Interpretation, and Clinical Application for Clinicians
Includes Multiple Live Events. The next is on 12/09/2023 at 10:00 AM (EST)
-
Register
- Non-Member - $800
- Full Member - $500
- MOC Only - $800
- Community Member - $800
- Professional Member - $800
Course Date
December 9 & 10, 2023.
Course Description
The core elements of this course serve to educate healthcare providers about bone densitometry and osteoporosis and to apply standard practices to assure quality performance and interpretation of bone densitometry studies. The course is offered in two parts. The first day sets the standard to perform Quality DXA interpretation. Day 2 focuses on the clinical assessment, prevention, treatment and management of osteoporosis and the essential role that high-quality DXA plays in treatment initiation decisions and monitoring of osteoporotic patients. Individuals may register for either part of the course separately or as a combined program.
Target Audience
The course is most appropriate for those involved in the performance and interpretation of DXA scans and those managing patients with osteoporosis. It is open to MDs, PhDs, DOs, Nurse Practitioners, and Physician Assistants. Technologists may attend if they have previously taken the ISCD/IOF Osteoporosis Essentials for Technologists Course.
Learning Objectives
After attending the course, participants should be better prepared to:
- Describe appropriate clinical evaluation of patients at risk for fragility fracture.
- Summarize the value and importance of quality bone densitometry for the diagnosis of osteoporosis, assessment of fracture risk, and monitoring of BMD.
- Recognize errors in DXA analysis and reporting.
- Explain new and emerging guidelines that provide evidence-based information regarding skeletal health.
- Describe the use of current and new pharmacologic therapies for the management and treatment of osteoporosis, including adverse effects.
Method of Participation
This activity will be offered live streamed via Zoom, allowing the learner to watch and ask questions in a live format on December 9 & 10, 2023. Learners will be asked to complete a post-course survey to indicate what they will change in their practice as a result of this activity.
Rates
Cancellation Policy
Attendee Cancellation Policy All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations ISCD reserves the right to cancel the program, change dates and/or meeting location. If a program is canceled, all program fees will be refunded automatically unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
ACCME Accreditation Statement:
The International Society for Clinical Densitometry is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians. This activity is provided by the International Society for Clinical Densitometry. For information about the accreditation of this program, please contact ISCD at +1.860.259.1000 or inquire at education@iscd.org.
AMA PRA Category 1 Credit(s)™
The International Society for Clinical Densitometry designates this live educational activity for a maximum of 11.5 AMA PRA Category 1 Credits™. Physicians should only claim credits commensurate with the extent of their participation in the activity.
Deadline to Claim Credit:
Participants will have 90 days from the activity end date to complete the activity survey and claim continuing education credit.
Schedule - Day 1 - All times Eastern Standard Time (NYC/USA)
Schedule - Day 2 -All times Eastern Standard Time (NYC/USA)
Dr Neil Binkley MD, CCD
Professor
University of Wisconsin Madison
Dr. Neil Binkley earned his medical degree from the University of Wisconsin and subsequently trained in Internal Medicine at the Marshfield Clinic. After several years in private practice, he returned to the University of Wisconsin and completed a Geriatrics fellowship. He is a Professor in the Divisions of Geriatrics and Endocrinology at the University of Wisconsin School of Medicine and Public Health. He is also Director of the UW Osteoporosis Clinical Research Program and Associate Director of the UW Institute on Aging. He is past President of the International Society for Clinical Densitometry, Associate Editor of Osteoporosis International and a member of the International Osteoporosis Foundation Committee of Scientific Advisors. His current research involves improvement in 25(OH)D measurement, evaluation of approaches to optimize assessment of vitamin D status, evaluation of functional assessment in older adults and the importance of sarcopenia in fracture risk. Dr. Binkley has published over 300 papers, served on expert committees and panels for AACE, ASBMR, IOF and ISCD.
Disclosure(s): Amgen: Consulting Fee, Contracted Research; Radius: Contracted Research
Christopher Shuhart MD, MHA, CCD
Director of the Bone Health and Osteoporosis Center
Swedish Medical Group
Dr. Shuhart is the founder and Director of the Bone Health and Osteoporosis Center at Swedish Medical Group in Seattle, Washington. He is Past-President of the International Society for Clinical Densitometry (ISCD) from 2019-2020, with multiple years in Executive and Board of Directors roles, and has served on numerous ISCD committees and task forces. He received ISCD's Paul Miller Service Award in 2022.
He is a co-author on the ISCD’s 2016 publication of “Best Practices” in the Journal of Clinical Densitometry, and was the Organizing Chair for the 2019 ISCD Position Development Conference (PDC) in Kuala Lumpur, Malaysia, as well as lead author of the 2019 PDC Executive Summary. He is the Administrative Chair for the 2023 PDC.
Dr. Shuhart received his medical degree from Dartmouth Medical School in 1987, and his Masters in Health Administration from the University of Washington in 2009. He is board certified in Family Medicine since 1990.
Disclosure: No financial relationships to disclose
S. Bobo Tanner, MD, CCD
Director of the Vanderbilt Osteoporosis Clinic
Vanderbilt University Medical Center
Bobo Tanner, MD, CCD is an Assistant Professor of Medicine at Vanderbilt University Medical Center in Nashville, TN in the Divisions of Rheumatology, Allergy and Immunology. He is the Director of the Vanderbilt Osteoporosis Clinic. His education includes an AB from Harvard University, and an MD from Wake Forest University. He completed his training in Internal Medicine, Rheumatology, and Allergy & Immunology at Vanderbilt University and served as Registrar in Rheumatology at the Royal Free Hospital, London, England. Dr. Tanner has been a member of the International Society for Clinical Densitometry (ISCD) since 1996 and is a Past- President of the ISCD. He is an Osteoporosis Essentials Course instructor, serves on the OE Update Committee and CME Committee. He was awarded Clinical Densitometrist of the year in 2007 by the ISCD and was Co-Chair of the ISCD Annual Meeting in 2006. He is a reviewer for the Journal of Clinical Densitometry and is on the editorial board of Therapeutic Advances in Musculoskeletal disease. He has also participated in numerous advisory boards and has given a variety of CME presentations. His research has been presented in regional, national, and international academic meetings.
Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen
Course Planning Committee
Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius
Sarah Morgan, MD, RD, CCD - No Financial Relationships to Disclose
Steven Petak, MD, JD, MACE, FACP, CCD - Fees for Non-CME Services: Amgen, Alexion
Christopher Shuhart, MD, CCD - No Financial Relationships to Disclose
S. Bobo Tanner, MD, CCD - Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen
Course Content Reviewers
Carolyn Crandall, MD, CCD - No Financial Relationships to Disclose
Monique Carroll, RT, CBDT - No Financial Relationships to Disclose
Brian Englander, MD - No Financial Relationships to Disclose
Ranjodh Gill, MD, CCD - No Financial Relationships to Disclose
Heidi Kecskemethy, MS Ed, RDN, CSP, CBDT - No Financial Relationships to Disclose
Adrian Lau, MD, FRCPC, MScCH, - CCD No Financial Relationships to Disclose
Orhan Oz, MD, PhD, CCD - No Financial Relationships to Disclose
December 2023 Course Faculty
Christopher R. Shuhart, MD, MHA - No Financial Relationships to Disclose
Neil Binkley, MD, CCD, CBDT - Consulting Fee: Amgen; Contracted Research: Radius
S. Bobo Tanner, MD, CCD Disclosures: Consulting Fees: AMGA, CSL Behring, Radius, Ultragenyx; Fees for Non-CME Services: Regeneron, Sanofi/GENZYME; Contracted Research: Amgen
Statement of Independence
The ISCD maintains a policy on the use of commercial support, which ensures that all educational activities sponsored by the ISCD provide in-depth presentations that are fair, balanced, independent, and scientifically rigorous. ISCD requires faculty, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ISCD for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. Individual disclosures are included in the course material. No Commercial Support has been provided for this activity
Disclaimer
The information and suggestions presented at the courses, seminars and other programs sponsored by ISCD and other collaborating societies are subject to change and therefore should serve only as a foundation for further investigation and study. Any forms presented at our seminars or programs are samples only and are not necessarily authoritative. All information, procedures, and forms contained or used in such seminars or programs should serve only as a guide for use in specific situations.
Disclosure of Unlabeled Use
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. ISCD does not recommend the use of any agent outside of the labeled indications. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for a discussion of approved indications, contraindications, and warnings.
Privacy & Confidentiality Statement
The ISCD will record the learner’s personal information as provided on evaluations to allow for the issuance and tracking of CME/CE certificates. The ISCD may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its educational program. No individual performance data or any other personal information collected for evaluations will be shared with third parties
Attendance Cancellation Policy
All changes in registration must be made in writing to education@iscd.org. Cancellations received 30 days prior to the start of the program are eligible for a full refund minus a $50 administrative fee. Cancellations received less than 30 days prior to the start of the course will not be refunded.
Course Changes or Cancellations
ISCD reserves the right to cancel the program, change dates, how the course is taught, and/or meeting location. If a program is canceled, all program fees will be refunded unless the registered participant elects to transfer to another program. Participants will be notified of any changes within 21 days of the course start date.
